News
Type of insurance linked to length of survival after lung surgery
- Author:
- Jim Kling
Having public or a combination of public and private insurance was associated with worse 10-year overall survival.
News
Thoracic cancer approvals differ at FDA, EMA
- Author:
- Jim Kling
The EMA had fewer approvals and took longer to make decisions.
News
In metastatic NSCLC, better QoL outcomes tied to better outcomes
- Author:
- Jim Kling
But the authors of new research also found potential evidence that industry sponsorship may lead to a spin on QoL outcomes.
News
Patients with IBD express need for psychosocial support
- Author:
- Jim Kling
- Carolyn Crist
AGA launches My IBD Life campaign to support patients with IBD and encourage providers to play a role.
News
Patient-based mouse MVID model hints at mechanism
- Author:
- Jim Kling
A method using gene editing at the two-cell stage recreated in mice the phenotype of a patient with two separate mutations.
News
Defensiveness may drive refusal for colon cancer screening
- Author:
- Jim Kling
An Irish study pinpoints excuses for putting off screening and discounting one’s risk of colorectal cancer.
News
An earlier hep B biomarker for clinical outcomes?
- Author:
- Jim Kling
Levels of a core-related antigen marker plunge years before a drop in the surface antigen, finds a natural history study of patients with chronic...
News
MS looks homogeneous
- Author:
- Jim Kling
An analysis of clinical factors and treatment responses calls for personal rather than precision medicine.
News
Portable MRI has potential for MS
- Author:
- Jim Kling
A blinded study showed good agreement with high-field MRI for some applications, but more development is needed.
News
A better MS measure?
- Author:
- Jim Kling
A ‘digital carpet’ may provide more granular information about functional decline in patients with MS.
News
MOGAD: Immunotherapy predicts fewer relapses
- Author:
- Jim Kling
IVIG therapy appears to be the most effective for reducing relapses.
News
To prevent MS, should we target EBV?
- Author:
- Jim Kling
Can a vaccine against EBV reduce MS incidence on a population level? Two experts debate.
News
Differential diagnosis in MS: What to watch for
- Author:
- Jim Kling
‘Red flags’ suggest something other than MS.
News
Use of diagnostic mammograms is inconsistent, survey finds
- Author:
- Jim Kling
Many employ diagnostic mammograms for posttreatment surveillance, but benefit is unknown.
News
Colorectal cancer treatment outcomes in older adults
- Author:
- Jim Kling
Disease-free survival boosted by adjuvant therapy completion, but only about half of patients finish.